Response evaluation in mesothelioma: Beyond RECIST

Lung Cancer. 2015 Dec;90(3):433-41. doi: 10.1016/j.lungcan.2015.08.012. Epub 2015 Aug 22.

Abstract

Malignant pleural mesothelioma (MPM) typically demonstrates a non-spherical growth pattern, so it is often difficult to accurately categorize change in tumour burden using size-based tumour response criteria (e.g., WHO (World Health Organisation), RECIST (Response Evaluation Criteria in Solid Tumours) and modified RECIST). Functional imaging techniques are applied to derive quantitative measurements of tumours, which reflect particular aspects of the tumour pathophysiology. By quantifying how these measurements change with treatment, it is possible to observe treatment effects. In this review, we survey the existing roles of CT and MRI for the management of MPM, including the currently applied size measurement criteria for the assessment of treatment response. New functional imaging techniques, such as positron emission tomography (PET), diffusion-weighted MRI (DWI) and dynamic contrast-enhanced MRI (DCE-MRI) that may potentially improve the assessment of treatment response will be highlighted and discussed.

Keywords: CT; DCE-MRI; DWI; Mesothelioma; PET; Treatment response evaluation.

Publication types

  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Disease Management
  • Humans
  • Lung Neoplasms / diagnosis*
  • Lung Neoplasms / therapy
  • Magnetic Resonance Imaging / methods
  • Mesothelioma / diagnosis*
  • Mesothelioma / therapy
  • Mesothelioma, Malignant
  • Neoplasm Staging
  • Positron-Emission Tomography / methods
  • Response Evaluation Criteria in Solid Tumors
  • Tomography, X-Ray Computed / methods
  • Treatment Outcome
  • Tumor Burden